Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. (KOSDAQ:A217330) from Jeon Byung Hee and others for KRW 110 billion on December 19, 2023. Transaction is financed through it's own funds.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11,250 KRW | 0.00% | -9.93% | -16.79% |
1st Jan change | Capi. | |
---|---|---|
-16.79% | 184M | |
-27.67% | 9.87B | |
-17.30% | 2.74B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. from Jeon Byung Hee and others for KRW 110 billion